Johnson & Johnson Pauses COVID Vaccine Trials After ‘Unexplained Illness’
By: Jeremy Loffredo
Johnson & Johnson temporarily paused Phase 3 clinical trials of its COVID-19 vaccine on Monday after one participant experienced what the company termed “an unexplained illness.”
The multinational maker of packaged consumer goods, medical devices and pharmaceuticals declined to provide details about the reaction or illness, leaving the public and thousands of other trial participants in the dark.
In a press release, the company said its decision to withhold details was made out of respect for the trial participant’s privacy. But the company also said the illness “might be related to a vaccine.”
According to Johnson & Johnson’s clinical trial guidelines, trials are paused only if participants experience a vaccine-related adverse event. The Phase 3 study began on Sept. 23 with researchers planning to enroll 60,000 participants in the U.S. and other countries.
Moreover, the Johnson & Johnson trial uses a sodium chloride solution (saline) as a placebo. Saline injections, regarded by the scientific community as harmless, are widely accepted as a valid placebo control in vaccine trials.
In September, the director of the National Institutes for Health, Francis Collins, told reporters that vaccine trials taking place as part of “Operation Warp Speed” are larger and more rigorous than ever before.
Yet the Johnson & Johnson trial doesn’t include any pregnant women, which makes it impossible to know if the vaccine being developed by the company might harm them or their children. All female trial participants of “childbearing potential” are required to practice “an acceptable effective method of contraception” until three months after getting the experimental vaccine.
The Data and Safety Monitoring Board, made up of a group of scientists and biostatisticians whose identities aren’t publicly known, will investigate and decide whether or not the Johnson & Johnson trials can continue.
The U.S. government already has a deal with Johnson & Johnson to buy 100 million doses of its experimental vaccine for $1 billion.
This isn’t the first time in recent history that Johnson & Johnson has faced public scrutiny regarding the safety of its products. In July 2018, a St. Louis jury awarded nearly $4.7 billion in damages to 22 women and their families who claimed the carcinogenic asbestos in Johnson & Johnson talcum powder caused their ovarian cancer. Earlier this month, Johnson & Johnson agreed to pay more than $100 million to resolve more than 1,000 lawsuits blaming its baby powder for causing cancer.
But the company won’t face a similar fate if it brings to market a COVID-19 vaccine that subsequently is found to cause illness or injuries. That’s because in March 2020, the U.S. Department of Health and Human Services issued a declaration under the Public Readiness and Emergency Preparedness Act or PREP Act that provides immunity “against any claim of loss caused by, arising out of, relating to, or resulting from the manufacture, distribution, administration, or use of medical countermeasures,” including vaccines.
The declaration indemnifies Johnson & Johnson and other vaccine makers against lawsuits, regardless of whether their new vaccines produce harmful effects.
Johnson & Johnson is the third “Operation Warp Speed” participant to report possible adverse reactions. In May, Moderna’s vaccine was shown to have a 20% “serious” injury rate in its high-dose group — one participant in the Moderna trial said he became “the sickest in his life” after taking the vaccine.
In September, AstraZeneca paused its vaccine trial after a participant suffered symptoms consistent with transverse myelitis, a neurological disorder that can result in weakness of the limbs, problems emptying the bladder and paralysis.
AstraZeneca has since resumed clinical trials in the UK, Brazil, India and South Africa. But the trials remain on hold in the U.S.
This article Johnson & Johnson Pauses COVID Vaccine Trials After ‘Unexplained Illness’ originated on Children’s Health Defense and has been re-published here on TLB by ‘contribution’ with attribution to it’s author Jeremy Loffredo and Children’s Health Defense.
TLB Editors Note: This is World Mercury Project on steroids! TLB highly recommends you click on the image below, visit this great website, and do whatever you can to help see this vital forum succeed … for the sake of our children !!!
Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. CHD is planning many strategies, including legal, in an effort to defend the health of our children and obtain justice for those already injured. Your support is essential to CHD’s successful mission.
Stay tuned to …
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.